Medindia

X

New AMG 479 Phase 2 Data Show Antitumor Activity in Patients With Metastatic Pancreatic Cancer

Friday, June 4, 2010 General News J E 4
Advertisement
AMG 479 Extended Progression-Free Survival And Overall Survival Compared To Gemcitabine Alone

CONTACT: Amgen, Thousand Oaks

Leanne Madison: +1 (805) 603-9241 (media)

Arvind Sood: +1 (805) 447-1060 (investors)

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
VitaminSpice Files United States and Worldwide Pat...
S
Jiangbo Pharmaceuticals, Inc. Receives Approval to...